Notably, two genes showing the largest decrease in expression upon MEN1 inhibition, PSAT1 and SLC1A5, were significantly associated with worse prognosis in a DLBCL patient cohort60 (Supplementary Fig. 8e). Here, SLC1A5 is linked to diffuse large B-cell lymphoma.